US Patent Issued to AJOU UNIVERSITY INDUSTRY-ACADEMIC COOPERATION FOUNDATION, KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY on Sept. 29 for "Interferon gene stimulator composition comprising indolizine derivative as active ingredient" (South Korean Inventors)

ALEXANDRIA, Va., Sept. 30 -- United States Patent no. 12,746,252, issued on Sept. 29, was assigned to AJOU UNIVERSITY INDUSTRY-ACADEMIC COOPERATION FOUNDATION (Suwon-si, South Korea) and KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (Seoul, South Korea).

"Interferon gene stimulator composition comprising indolizine derivative as active ingredient" was invented by Eunha Kim (Seoul, South Korea), Sanghee Lee (Seoul, South Korea), Sang-Kee Choi (Yongin-si, South Korea), Hyungi Kim (Seoul, South Korea) and Hee Ra Jung (Seongnam-si, South Korea).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to an interferon gene stimulator composition containing an indolizine derivative as an active ingr...